Consistent with the efficacy of HRF inhibitors in allergic disease models (see below), IgE-binding sequences (i.e., N19 and H3) are exposed on the molecular surface of HRF dimer (Figure 1a,b) [28]. This evidence concerns the gene TPT1 and allergic disease.